Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug.
It is shown that, under certain assumptions, one can estimate the difference between the effect of a treatment and that of a placebo even when the treatment has been given to all and only those patients who are at risk (as evidenced by a screening examination).